Omkar Pharmachem Limited (BOM:532167)

Omkar Pharmachem Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	-	5.4	5.4	5.4	2.7
Other Revenue	5.4	-	-	-	-
Revenue	5.4	5.4	5.4	5.4	2.7
Revenue Growth (YoY)	-	-	-	100.00%	500.00%
Cost of Revenue	1.61	1.61	1.39	1.75	1.51
Gross Profit	3.79	3.8	4.01	3.65	1.19
Selling, General & Admin	-	0.07	0.07	0.07	0.06
Other Operating Expenses	0.89	0.9	0.84	0.9	0.91
Operating Expenses	0.94	1.01	0.93	0.98	0.99
Operating Income	2.85	2.78	3.08	2.67	0.21
Interest Expense	-0.17	-0.29	-0.47	-0.56	-0.57
Interest & Investment Income	-	0.04	0.03	-	-
Other Non Operating Income (Expenses)	0.02	-	-	-	-0
EBT Excluding Unusual Items	2.7	2.53	2.65	2.11	-0.36
Pretax Income	2.7	2.53	2.65	2.11	-0.36
Income Tax Expense	0.69	0.64	0.67	0.27	-2.57
Net Income	2.01	1.89	1.98	1.83	2.21
Net Income to Common	2.01	1.89	1.98	1.83	2.21
Net Income Growth	6.24%	-4.40%	8.03%	-17.30%	-
Shares Outstanding (Basic)	10	10	10	10	10
Shares Outstanding (Diluted)	10	10	10	10	10
Shares Change (YoY)	0.01%	-	-	-	-
EPS (Basic)	0.20	0.19	0.20	0.18	0.22
EPS (Diluted)	0.20	0.19	0.20	0.18	0.22
EPS Growth	6.23%	-4.40%	8.97%	-18.02%	-
Free Cash Flow	2.4	2.86	2.76	1.96	0.22
Free Cash Flow Per Share	0.24	0.28	0.27	0.19	0.02
Gross Margin	70.24%	70.28%	74.28%	67.57%	44.19%
Operating Margin	52.76%	51.56%	57.07%	49.41%	7.70%
Profit Margin	37.20%	35.02%	36.63%	33.91%	82.00%
Free Cash Flow Margin	44.35%	53.02%	51.09%	36.30%	8.30%
EBITDA	2.9	2.83	3.11	2.69	0.22
EBITDA Margin	53.70%	52.43%	57.57%	49.76%	8.07%
D&A For EBITDA	0.05	0.05	0.03	0.02	0.01
EBIT	2.85	2.78	3.08	2.67	0.21
EBIT Margin	52.76%	51.56%	57.07%	49.41%	7.70%
Effective Tax Rate	25.59%	25.20%	25.22%	13.02%	-
Revenue as Reported	5.42	5.44	5.43	5.4	2.7
Advertising Expenses	-	0.03	0.03	0.03	0.03

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.